title: Combination therapy of infliximab and azathioprine reduces disease progression in Crohn's disease.
authors.forename: S
authors.initials: S
authors.lastname: Din
authors.forename: C J
authors.initials: CJ
authors.lastname: Cochrane
authors.forename: C L
authors.initials: CL
authors.lastname: Noble
authors.forename: J
authors.initials: J
authors.lastname: Satsangi
authors.forename: I D R
authors.initials: ID
authors.lastname: Arnott
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use*; D003424:Crohn Disease / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D000069285:Infliximab; D001379:Azathioprine